Ramiven (Abemaciclib)

Ramiven Tablet(Abemaciclib)

(4 customer reviews)
(4 customer reviews)

Active Ingredient (Generic Name): Abemaciclib
Indication: Treatment of metastatic breast cancer
Manufacturer: Eli Lilly and Company India
Packaging: 7 Tablets in Blister
Delivery Time: 6 To 15 days

Ramiven Tablet contains Abemaciclib, a CDK4/6 inhibitor used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced breast cancer.

Category:

Share:

Ramiven 100 Mg Tablet (Abemaciclib)

Tablets Price Price/unit Quantity Add To Cart
7 Tablet/s $230 $32.86 /Tablet
14 Tablet/s $400 $28.57 /Tablet
28 Tablet/s $750 $26.79 /Tablet
Want to order in bulk / B2B price? Send Inquiry

Ramiven 150 mg (Abemaciclib)

Tablets Price Price/unit Quantity Add To Cart
7 Tablet/s $230 $32.86 /Tablet
14 Tablet/s $400 $28.57 /Tablet
28 Tablet/s $750 $26.79 /Tablet
Want to order in bulk / B2B price? Send Inquiry

Ramiven 200 mg (Abemaciclib)

Tablets Price Price/unit Quantity Add To Cart
7 Tablet/s $230 $32.86 /Tablet
14 Tablet/s $400 $28.57 /Tablet
28 Tablet/s $750 $26.79 /Tablet
Want to order in bulk / B2B price? Send Inquiry

What Our Customer Says

Last Updated on
Medically Written by Profile Photo Dr. Eliza Parker
Profile Photo
Trusted Source
Dr. Eliza Parker
View more
Last Updated on
Medically Reviewed by Profile Photo Dr. Jeremy Burston
Profile Photo
Trusted Source
Dr. Jeremy Burston
View more

4 reviews for Ramiven Tablet(Abemaciclib)

  1. Darcy Banfield

    Darcy Banfield

    I’ve ordered Ramiven Tablets twice now, and both times delivery was on time.

  2. Brock Harold

    Brock Harold

    The quality of Ramiven Tablet exceeded my expectations.

  3. Nadia Carter

    Nadia Carter

    Ramiven Tablet was easy to take as prescribed, and I noticed gradual changes during treatment. There were some side effects, but overall the treatment was manageable for me.

  4. Isaac Bennett

    Isaac Bennett

    Ramiven Tablet treatment routine and follow-up visits were manageable.

Add a review

Your email address will not be published. Required fields are marked *